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Polychlorinated biphenyls (PCBs) are a
class of industrial chemicals that persist in
the environment. In laboratory animals
PCBs cause a variety of biological effects
including cancer, immunotoxicity, neuro-
toxicity, and hepatotoxicity as well as der-
matitis, edema, induction of cytochrome
P450, and increased mixed-function oxi-
dase activities. Although many of these
effects have been related to activity of the
Ah receptor, recent studies suggest that
mechanisms independent of this receptor
may also be important (1-3). For example,
investigations concerning the neurotoxicity
ofPCBs suggest that ortho-substituted con-
geners, which have little affinity for the Ah
receptor, cause greater decreases in neuro-
transmitter levels (1) and perturbations of
Ca2+ homeostasis in neural cells (3,4) than
planar congeners, which bind the Ah recep-
torwith high affinity.
Studies in our laboratory indicate similar
results in neutrophils. When exposed in
vitro to Aroclor 1242, a PCB mixture, neu-
trophils are activated to undergo degranula-
tion and to produce superoxide anion (02-)
These effects do not appear to involve Ah
receptor activity since similar results are
observed with an ortho-substituted con-
gener, 2,2',4,4'-tetrachlorobiphenyl
(2,2',4,4'-TCB), whereas aplanar congener,
3,3',4,4'-tetrachlorobiphenyl (3,3',4,4'-
TCB), does not alter neutrophil function
(5). Furthermore, the activation of neu-
trophils by PCBs appears to involve mecha-
nisms similar to those reported by
Kodavanti et al. (4,5) for neural cells,
namely, the activation ofphospholipase C,
the production of inositol 1,4,5-trisphos-
phate (1P3), and the subsequent mobiliza-
tion ofintracellular calcium (6). Activation
ofphospholipase C appears to be important
in PCB-induced stimulation ofneutrophils
because the concentration-response rela-
tionship is similar for production ofinositol
phosphates and neutrophil activation, and
IP3 accumulation precedes the onset of02-
production in neutrophils exposed to
PCBs. Furthermore, activity ofthis enzyme
parallels production of02-; i.e., 2,2',4,4'-
TCB causes the accumulation of inositol
phosphates but 3,3',4,4'-TCB does not
(6). Finally, 8-(N,N-diethylamino)octyl-
3,4,5-trimethoxybenzoic acid, an inhibitor
ofmobilization ofintracellular calcium, sig-
nificantly attenuates PCB-induced neu-
trophil activation, suggesting that IP3-
induced mobilization of intracellular calci-
um plays an important role in the activa-
tion of neutrophils by PCBs (7). These
results are consistent with the hypothesis
that PCBs activate neutrophils by a mecha-
nism that involves phospholipase C. Little is
known, however, about subsequent signal-
ing pathways involved in the activation of
neutrophils by PCBs.
Phospholipase C appears to play an
important role in neutrophil activation in
response to several physiologic activators of
neutrophil function, induding the chemotac-
tic peptide formyl-methionyl-leucyl-phenyl-
alanine (fMLP) (8,9), opsonized zymosan,
and antigen-antibody complexes (10). Several
enzymes are activated subsequent to the
increase in phospholipase C activity, indcuding
phospholipases A2 and D, as well as protein
kinase C (11). Activation ofthese enzymes is
important in regulation, initiation, and/or
maintenance of neutrophil activation. For
example, inhibitors ofphospholipase A2 such
as quinacrine and 4-bromophenacyl bromide
(BPB) abolish 02- production in response to
fMLP and opsonized zymosan, as well as to
phorbol myristate acetate (PMA) (12-14),
suggesting that activity ofphospholipaseA2 is
required for activation of the NADPH oxi-
dase responsible for reduction ofO2 toO 2--
Because early signal transduction events are
similar in neutrophils exposed to PCBs and
other stimuli such as fMLP, it is possible that
subsequent signal transduction mechanisms
are also similar. Therefore, the purpose ofthe
present study was to determine whether
PCBs activate neutrophils by a mechanism
that involves phospholipase A2 and conse-
quent release ofarachidonic acid.
Materials and Methods
Chemicals. Aroclor 1242, 2,2',4,4'-TCB,
3,3',4,4'-TCB, and 3,3'4,4',5-pentachloro-
biphenyl (PeCB) were obtained from
ChemService (West Chester, Pennsylvania).
The congeners were reported by the manu-
facturer to be greater than 99% pure. fMLP,
PMA, cytochalasin B, cytochrome C, super-
oxide dismutase (SOD), quinacrine, BPB,
xanthine, and xanthine oxidase were
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obtained from Sigma Chemical Company
(St. Louis, Missouri). WEB 2086 was
obtained from Boehringer Ingelheim
(Ridgefield, Connecticut) and zileuton
from Abbott Laboratories (Chicago,
Illinois). Manoalide was purchased from
Biomol (Plymouth Meeting, Pennsylvania),
and 3H-arachidonate was obtained from
DuPont (Boston, Massachusetts). For all
experiments Aroclor 1242 was dissolved in
methanol, and the congeners were dissolved
in dimethylformamide at a concentration of
10 mg/ml. Neutrophils received 1 pli/ml of
this stock solution, and control cells
received 1 p1 of the appropriate vehicle.
fMLP, PMA, and cytochalasin B were dis-
solved in DMSO and diluted so that the
final concentration ofDMSO was less than
1%. Manoalide and BPB were suspended in
ethanol so that the final concentration of
ethanol to which neutrophils were exposed
was less than 1%. Quinacrine was suspend-
ed in Hanks' balanced salt solution (HBSS).
Neutrophilisolation. We obtained glyco-
gen-elicited neutrophils from the peritoneal
cavities ofone to two male, Sprague-Dawley,
retired breeder rats per experiment (Charles
River Laboratories, Portage, Michigan) as
described previously (5). Briefly, rats were
anesthetized with diethyl ether and 30 ml
1% glycogen was injected intraperitoneally.
After 4 hr the rats were anesthetized again
and killed by decapitation. The peritoneum
was washed with 30 ml of heparinized (1
U/ml), 0.1 M phosphate-buffered saline
(PBS). The solution obtained from the peri-
toneum was collected, filtered through
gauze, and centrifuged at 5OOg for 7 min.
Contaminating red blood cells were lysed
with 15 ml of 0.15 M NH4Cl, and neu-
trophils were suspended to a final volume of
50 mlwith PBS and centrifuged for 7 min at
300g. Cells were washed once with PBS and
resuspended in HBSS.
Generation of 02- We measured 02-
production by neutrophils (2 x 106
cells/ml) in response to Aroclor 1242,
2,2',4,4'-TCB, 3,3',4,4'-TCB, 3,3',4,4'5-
PCB, PMA, and fMLP. In these and all
experiments with fMLP, neutrophils were
pretreated with cytochalasin B (4 pM) for
5 min because fMLP does not cause signifi-
cant 02- production in rat neutrophils in
the absence ofcytochalasin B (6,15).
We measured 02- production in the
presence and absence of the inhibitors of
phospholipase A2, BPB (1-100 pM),
quinacrine (1-200 pM), and manoalide
(0.1-10 pM). Neutrophils were preincu-
bated with BPB or quinacrine for 3 min or
with manoalide for 20 min before addition
ofstimuli. To test the role ofmetabolites of
arachidonic acid in neutrophil activation,
02- production was measured in stimulat-
ed neutrophils in the presence and absence
of aspirin or zileuton, inhibitors of
cyclooxygenase or 5-lipoxygenase, respec-
tively. We used the receptor antagonist for
platelet-activating factor (PAF), WEB
2086, to examine the potential involve-
ment of PAF. Neutrophils were incubated
with aspirin or WEB 2086 for 30 min or
with zileuton for 15 min before addition of
stimuli. In all experiments, cumulative 02-
production in response to stimulation was
measured over 20 min.
Detection of02. We measured 02-
generated by monitoring the reduction of
cytochrome C (10 mg/ml) in the presence
and absence of SOD (16). For every sam-
ple, two tubes were incubated, one to
which SOD (840 U/mI) was added before
stimulation and one to which SOD (840
U/mI) was added at the end ofincubation.
The amount ofcytochrome C reduced was
estimated from the difference in
absorbance (550 nm) between the cell-free
supernatant in the two tubes using an
extinction coefficient of18.5 cm-1 mM-,.
Phospholipase A2 inhibitors could
decrease the amount of 02- detected by
mechanisms unrelated to inhibition ofpro-
duction of 02- by neutrophils. To test
whether any apparent decrease in 02- pro-
duction by inhibitors of phospholipase A2
was due to scavenging of oxygen radicals,
we measured 02- generated during oxida-
tion of xanthine by xanthine oxidase in a
cell-free system in the presence and absence
of the compounds. Cytochrome C was
incubated for 5 min at 37°C with xanthine
(9 mg/ml) and xanthine oxidase (2.5 x 10-4
U/ml) in the presence or absence of
quinacrine, BPB, and manoalide. We deter-
mined the amount of02- generated byxan-
thine and xanthine oxidase bythe difference
in absorbance (550 nm) between tubes con-
taining both xanthine and xanthine oxidase
and tubes containing xanthine alone.
In addition, absorbance of reduced
cytochrome C was measured in the pres-
ence or absence of phospholipase A2
inhibitors to ensure that apparent inhibi-
tion ofneutrophil-generated 02- was not a
result ofquenching of absorbance by these
compounds. Cytochrome C was reduced by
02- generated from neutrophils exposed to
Aroclor 1242 as described above, and
absorbance at 550 nm was measured in the
cell-free supernatant fluids after the addi-
tion ofquinacrine, manoalide, BPB, or the
appropriate vehicle. There were no differ-
ences in absorbance values in the presence
and absence of inhibitors of phospholipase
A2.
Determination ofcytotoxicity. Cyto-
toxicity was determined by release of the
cytosolic enzyme lactate dehydrogenase
(LDH). Neutrophils were incubated with
manoalide, BPB, or quinacrine as described
above, and LDH activity was determined
in the cell-free supernatant fluids as
described by Bergmeyer and Bernt (17). A
separate aliquot of neutrophils was lysed
with Triton-X and sonication, and total
LDH activity was determined in the cell-
free supernatant fluid ofthis lysate so that
cytotoxicity could be expressed as the per-
centage oftotal LDH released.
Labeling of neutrophils with 3H-
arachidonic acid. Neutrophils (107/ml)
were suspended in Mg2+-free and Ca2+-free
HBSS containing 0.1% bovine serum albu-
min and incubated in the presence of 0.5
pCi/ml 3H-arachidonic acid (specific activ-
ity = 180-240 Ci/mM) for 2 hr gently
shaking at 370C. At the end ofthe labeling
period, neutrophils were washed 2 times
with Mg2+-free and Ca2+-free HBSS and
resuspended in HBSS containing albumin,
Ca2+ and Mg2+. The cell count was adjust-
ed so that the final concentration of neu-
trophils was 2 x 106/ml. The incorporation
of 3H-arachidonate was routinely greater
than 80% of the total radioactivity added
to the cells.
Stimulated release of3H-arachidonate.
Neutrophils labeled as described above
were stimulated with either fMLP, PMA,
Aroclor 1242, 2,2',4,4'-TCB, 3,3',4,4'-
TCB, 3,3',4,4',5-PeCB, or the appropriate
vehicle, and release of3H-arachidonate was
measured at various times. In some experi-
ments, we measured 3H-arachidonate
release in the presence and absence of
manoalide (10 pM). At the end of each
incubation, neutrophils were placed on ice
and centrifuged at 0°C for 10 min. The
cell-free supernatant fluids were transferred
to vials containing scintillation cocktail (14
ml), and the total radioactivity in each
sample was determined by liquid scintilla-
tion counting. To determine the total cel-
lular uptake of 3H-arachidonate, for each
experiment total cellular radioactivity was
measured in a 1-ml aliquot ofwashed cells
(2 x 106 cells/ml).
Statistical analysis. Results are
expressed as means ± standard error of the
mean (SEM). Results for 3H-arachidonate
are expressed as percentage oftotal cellular
radioactivity released into the medium.
Data were analyzed by analysis ofvariance,
and group means were compared using the
Student-Newman-Keuls' test. We per-
formed appropriate transformations on all
data that did not follow a normal distribu-
tion (e.g., percent data). Neutrophils taken
from a single rat or pooled from two rats
were used to obtain data for a single repli-
cate or n. For all studies, the criterion for
statistical significance wasp < 0.05.
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Figure 1. Percent inhibition of superoxide anion (°2-) generation by (A) 4-bromophenacyl bromide (BPB) and (B) manoalide. 02- production was measured in neu-
trophils as described in Materials and Methods. Neutrophils (2 x 106 cells/ml) were incubated at37°C for 3 min in the presence of BPB or vehicle or for 20 min in
the presence of manoalide or vehicle and then stimulated for 20 min with Aroclor 1242 (10 pg/ml), phorbol myristate acetate (PMA; 20 ng/ml) or formyl-methionyl-
leucyl-phenylalanine (fMLP; 1 pM). Cytochalasin B (4 pM) was added 5 min before stimulation with fMLP. 02- production in response to Aroclor 1242, PMA, and
fMLP was (A) 25.6 ± 5.8, 45.8 ± 14.5, and 19.6 ± 4.6 nmol/106 cells/20 min and (B) 13.8 ± 5.1, 21.3 ± 2.4, and 14.9 ± 3.9 nmol/106 cells/20 min. *Significantly different
from respective value obtained in the absence of inhibitor; n= 4-5.
Results
No 02- was produced by unstimulated
neutrophils either in the presence or
absence ofthe phospholipase A2 inhibitors
BPB, manoalide, or quinacrine (data not
shown). The effect ofBPB on 02- produc-
tion in neutrophils stimulated with Aroclor
1242, fMLP, and PMA is shown in Figure
1A. Cumulative 02- release in response to
Aroclor 1242 was 25.6 ± 5.8 nmol/106
cells/20 min. Responses to PMA and fMLP
were included so that effects ofPCBs could
be compared to those of other neutrophil
stimuli with well-studied mechanisms of
action. PMA and fMLP produced 45.8 ±
14.5 and 19.6 ± 4.6 nmol/106cells/20 min,
respectively. 02- produced by all three
agents was significantly different from
unstimulated neutrophils. 02- generated in
the presence ofAroclor 1242 was signifi-
cantly inhibited by 1 pM BPB and abol-
ished by 10 pM BPB (Fig. IA). Similar
inhibition of fMLP- and PMA-induced
02- production was observed.
Manoalide also inhibited 02- produc-
tion in neutrophils exposed to Aroclor
1242, fMLP, and PMA; however, the con-
centration-response relation differed slight-
ly in neutrophils exposed to fMLP and
PMA compared to Aroclor 1242 (Fig. IB).
Inhibition of fMLP- and PMA-induced
02- production was complete in the pres-
ence of 1 pM manoalide, i.e., maximal,
inhibition of 02- generation in the pres-
ence ofAroclor 1242 was achieved with 10
pM manoalide (Fig. iB). Neither BPB nor
manoalide was cytotoxic to neutrophils in
the presence of stimuli (Fig. 2). In addi-
tion, neither of these phospholipase A2
inhibitors scavenged 02- radicals at con-
centrations that inhibited neutrophil 02-
production as evidenced by the inability of
these agents to reduce the amount of 02-
detected in the presence of xanthine and
xanthine oxidase (Table 1). The quantity
of02- measured in neutrophils exposed to
Aroclor 1242, fMLP, or PMA was also
decreased in a concentration-dependent
manner by quinacrine (Fig. 3); however,
this compound inhibited the amount of
02- detected in the presence of xanthine
and xanthine oxidase in a cell-free system
(Table 1), suggesting that quinacrine scav-
enges 02- radicals.
The effect of BPB and manoalide to
inhibit 02- production by Aroclor 1242-
stimulated neutrophils suggested that
Aroclor 1242 activates phospholipase A2.
A consequence ofactivation ofthis enzyme
is liberation of arachidonic acid from
membrane phospholipids. Accordingly, we
examined the kinetics of 3H-arachidonate
release in response to Aroclor 1242.
Experiments were performed in the pres-
ence ofalbumin to inhibit the metabolism
and reacylation of arachidonic acid; there-
fore, the data represent the cumulative
release of arachidonic acid. Little radiola-
beled arachidonate was released from neu-
trophils in the absence of activation (Fig.
4). Significant release of 3H-arachidonate
was observed within 5 min from neu-
trophils exposed to Aroclor 1242, and no
further release was observed after this time
(Fig. 4A). 3H-arachidonate release in
response to fMLP occurred within 2 min,
-80 w l _ Manoalide
_2 40 1 |s s l1 gns
0
Aroclor 1242 PMA fMLP
Figure 2. Lack of cytotoxicity of manoalide and 4-
bromophenacyl bromide (BPB). Neutrophils were
exposed to Aroclor 1242, phorbol myristate
acetate (PMA) or formyl-methionyl-leucyl-pheny-
lalanine (fMLP) in the presence or absence of
manoalide (10 pM) or BPB (100 pM) as described
in the legend to Figure 1, and cytotoxicity was
assessed from release of the cytosolic enzyme
lactate dehydrogenase (LDH) as described in
Materials and Methods. Percent release of LDH
from unstimulated neutrophils was 7.5 ± 1.6%; n =
3. There were no significant differences between
groups.
with no further release thereafter (Fig. 4B).
The magnitude of release of3H-arachido-
nate was greater in neutrophils exposed to
Aroclor 1242 when compared to fMLP
(Fig. 4A, B). In neutrophils exposed to
PMA, a small but statistically significant
release of 3H-arachidonate was observed,
but not until 20 min after stimulation
(Fig. 4C).
Because release of arachidonic acid can
occur by mechanisms independent ofphos-
pholipase A2 (18), we investigated the
effect of manoalide on PCB-, PMA-, and
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fMLP-induced 3H-arachidonate release. As
can be seen in Figure 5A, manoalide, at a
concentration which abolished O2-produc-
tion by all three agents (Fig. 2B), signifi-
cantly inhibited the release of3H-arachido-
nate in neutrophils stimulated withAroclor
1242. Similar results were observed in neu-
trophils stimulated with fMLP (Fig. 5B).
PMA induced a small increase in arachi-
donic acid release that was significant in
the absence, but not the presence of
manoalide, and these values were not sig-
nificantly different from each other (Fig.
5C). Similar results were obtained with
BPB (data not shown).
The release of3H-arachidonate and the
production of 02- by neutrophils in
response to stimulation with Arodor 1242
were concentration dependent (Fig. 6A).
Likewise, exposure to 2,2',4,4'-TCB
caused generation ofO2- and release of3H-
arachidonate in a concentration-dependent
manner (Fig. 6B), whereas 3,3',4,4'-TCB
Table 1. Detection of 02- generated from xanthine
and xanthine oxidase8
Phospholipase 02-detected
A2inhibitor Concentration (pM) (nmol/ml)
Vehicle 0 33 ± 6.2
Quinacrine 100 4.7 ± 2.7*
200 6.0 ± 3.6*
Manoalide 10 27 ± 0.1
4-Bromophenacyl 100 29 ± 4.8
bromide
"The effect of inhibitors of phospholipase A2 on 02-
generated from a mixture of xanthine (9 mg/ml)
and xanthine oxidase (2.5 x 10-4 U/ml) was mea-
sured in a cell-free system. 02- generated was
assessed as described in Materials and Methods.
The amount of 02- detected was significantly
decreased in the presence of quinacrine, but not
manoalide or 4-bromophenacyl bromide.
*Significantly different from value obtained in the
presence ofvehicle; n= 3.
c AlE PMA *0 fMLP
4=
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Figure 3. Quinacrine induced-inhibition of 02- gen-
eration. Experiments were performed as
described in the legend to Figure 1, except that
neutrophils were incubated at37°C for3 min in the
presence or absence of quinacrine prior to stimu-
lation for 20 min. *Significantly different from
respective value obtained in the absence of
quinacrine; n= 4-5.
failed to elicit either response in neu-
trophils (Fig. 6C). A small but significant
release of3H-arachidonate was observed in
neutrophils exposed to 3,3',4,4',5-PeCB;
however, this congener did not cause sig-
nificant production of02- (Fig. 6D).
Arachidonic acid is metabolized in the
neutrophil by cyclooxygenase and 5-lipoxy-
genase to products that can alter neutrophil
function (19). To test whether arachidonic
acid metabolites were involved in activa-
tion ofthe NADPH oxidase, we measured
02- production in stimulated neutrophils
in the presence and absence ofthe inhibitor
ofcyclooxygenase, aspirin, or the inhibitor
of 5-lipoxygenase, zileuton (Table 2). 02-
production in neutrophils exposed to
Aroclor 1242 was not affected by these
inhibitors at concentrations that have been
shown to attenuate eicosanoid production
(20). Similarly, no effect ofthese inhibitors
on fMLP- or PMA-induced 02- produc-
tion was observed. PAF is a product of
phospholipase A2, which has been suggest-
ed to be involved in the generation of02-
in rabbit neutrophils (21); therefore, exper-
iments with the PAF receptor antagonist
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were labeled as described in Materials and
Methods and incubated in the presence and
absence of (A) Arocior 1242, (B) formyl-methionyl-
leucyl-phenylalanine (fMLP), or (C) phorbol myris-
tate acetate (PMA) as described in the legend to
Figure 1. Release of 3H-arachidonic acid into the
extracellular medium was determined as described
in Materials and Methods. Data are expressed as
percent of total cellular radioactivity. *Statistically
different from respective results obtained in the
presence ofvehicle; n=3- 4.
WEB 2086 were performed to test for any
involvement of this product. WEB 2086,
at concentrations which significantly atten-
uate PAF-induced responses (22), did not
alter the generation of 02- by Aroclor
1242, PMA, or fMLP (Table 2).
Discussion
We have demonstrated previously that the
PCB mixture Aroclor 1242 activates isolat-
ed rat neutrophils to produce 02- (5). In
the present study, Aroclor 1242 stimulated
the release ofarachidonic acid by a mecha-
nism involving phospholipase A2. The
release ofarachidonic acid and the produc-
tion of 02- in neutrophils exposed to
Aroclor 1242 occurredwith similar kinetics
and concentration-response relations. Two
inhibitors of phospholipase A2, BPB and
manoalide, caused concentration-depen-
dent inhibition of 02- production upon
exposure of rat neutrophils to Aroclor
10
40
...... ..s.... g |" >>Eg
,G,,, _0 Vehicle
30 M~Manoalide $ .
I _
E~~~ ~~ 10I10=' _ F i _ ' _
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Figure 5. The inhibitory effect of manoalide on
release of3H- arachidonic acid in neutrophils stim-
ulated with (A) Aroclor 1242, (B) formyl-methionyl-
leucyl-phenylalanine (fMLP), or (C) phorbol myris-
tate acetate (PMA). Neutrophils were labeled with
3H-arachidonic acid, preincubated with manoalide
(10 pM) or vehicle for 20 min, then stimulated as
described in Figure 1. Cumulative release of 3H-
arachidonate was measured over 20 min. Data are
expressed as percent oftotal cellular radioactivity.
*Statistically different from respective value
obtained in the absence of stimulus. **Statistically
different from respective value obtained in the
absence ofmanoalide; n = 4.
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Table2 Stimulated production of02- in the presence
of inhibitors of arachidonic acid metabolism and a
platelet-activating factor receptor antagonista
Stimulus
Concentration Aroclor 1242 PMA fMLP
Addition (pM) (10pg/ml) (20ng/ml) (1 pM)
Aspirin 0 37± 1.3 18±3.8 45±7.6
1 39±3.1 19±3.0 44±4.0
10 36±3.2 18±2.5 58±3.4
100 31±1.4 17±2.8 60±2.1
Zileuton 0 33±8 28±4.4 15±1.3
0.1 41±12 28±7.4 20±1.1
1 42±11 30±8.0 19±0.9
10 30±6.5 19±4.2 19±2.5
WEB2086 0 48± 11 27± 11 22± 5.3
1 47±9.6 26±11 21 ±5.8
10 45±9.4 25±12 20±4.2
100 37±7.7 26±9.3 18±4.3
Abbreviations: PMA, phorbol myristate acetate;
fMLP, formyl-methionyl-leucyl-phenylalanine.
INeutrophils (2 x 106 cells/ml) were treated with
aspirin, zileuton, WEB 2086, or vehicle as
described in Materials and Methods. Cytochalasin
B (4 pM) was added 5 min before stimulation with
0.1 1 10 fMLP. No O2- was produced by unstimulated neu-
trophils either in the presence or absence of ,3J4,4',5-Pentachlorobiphenyl (ig/mI) inhibitors; n 3-5. No significant differences were
--Y+A ;" nn^|+nn;l ..;|lI^ ;+I, IAI observed. rigure u. uoncentration-aepenaent reiease Ot U2- ana n-aracnilaonate in neutropniis stimuwatea witn (A)
Aroclor 1242, (B) 2,2',4,4'-tetrachlorobiphenyl (TCB), (C) 3,3',4,4'-TCB, or (D) 3,3',4,4',5-pentachloro-
biphenyl. Cumulative generation of 02- and release of 3H-arachidonate were measured in neutrophils
stimulated for 20 min with the indicated concentrations of PCBs, as described in Materials and Methods.
*Statistically differentfrom respective value obtained in the presence ofvehicle; n = 4.
1242. These inhibitors also attenuated the
release of 3H-arachidonate in prelabeled
neutrophils, suggesting that the inhibitory
effect of BPB and manoalide on 02- pro-
duction was a result of inhibition ofphos-
pholipase A2. Release of LDH by neu-
trophils was not altered in the presence of
these compounds (Fig. 2), indicating that
the inhibition of 02- generation was not
related to cytotoxicity. In addition, these
agents did not act by scavenging oxygen
radicals because reduction ofcytochrome C
by xanthine and xanthine oxidase was not
affected by either agent (Table 1).
Although other nonspecific effects of
these compounds cannot be ruled out
entirely, the argument that the effects on
02- production are due to inhibition of
phospholipase A2 is strengthened by the
use of compounds that inhibit phospholi-
pase A2 by different mechanisms.
Manoalide inhibits the enzyme by cova-
lently modifying selective lysine residues
within the protein (21), whereas BPB caus-
es irreversible inhibition by binding cova-
lendy to a histidyl residue at the active site
(21). Furthermore, quinacrine, which
inhibits phospholipase A2 by perturbing
the enzyme-substrate interface (21), also
decreased 02- measured in Aroclor 1242-
treated neutrophils. The results with
quinacrine, however, are difficult to inter-
pret because concentrations that inhibited
02- production by neutrophils also inhibit-
ed the reduction of cytochrome C by 02-
generated by xanthine and xanthine oxi-
dase (Table 1), suggesting that quinacrine
is capable ofscavenging 02- Thus, it is not
possible to know from these datawhat con-
tribution inhibition of phospholipase A2
made to the decrease in 02-detected from
activated neutrophils in the presence of
quinacrine. These results suggest that stud-
ies using quinacrine to relate phospholipase
A2 activity to the production of oxygen
radicals should be interpreted with caution.
Quinacrine is not the only inhibitor of
phospholipase A2 that has pleiotropic
effects. In general, all inhibitors ofphospho-
lipase A2 available at this time have been
shown to have effects unrelated to the inhi-
bition of phospholipase A2 (20,23-26).
Because of the lack of availability of an
inhibitor specific for phospholipase A2 it is
difficult to make definitive condusions con-
cerning the role of this enzyme in cellular
activation. Despite considerable efforts to
minimize the probability that nonspecific
effects ofthe inhibitors were responsible for
our results, the possibility remains that inhi-
bition of02- production by manoalide and
BPB occurred via other means. Forexample,
the inhibition of02- production in the pres-
ence of BPB and manoalide may have
resulted from the ability of these agents to
inhibit phosphoinositide-specific phospholi-
pase C (23,24), as this enzyme has been
shown to be involved in the activation of
neutrophils by fMLP and Aroclor 1242 (6).
However, this possibility seems unlikely
because inhibition of phospholipase C
occurs at higher concentrations of BPB
[IC50 = 100 pM (23)] and manoalide [IC50
= 80 liM (27)] than the concentrations
found to be effective in this study.
Furthermore, BPB and manoalide inhibited
the response to PMA, an agent that does not
involve activation of phospholipase C (28),
thus suggesting that the inhibitory effect of
these compounds on 02- was unrelated to
theirability to inhibit phospholipase C.
If activation of phospholipase A2 is
important in initiation ofproduction of02-
in response to stimuli, release of3H-arachi-
donic acid from prelabeled neutrophils
should precede generation of 02--
Significant release of 3H-arachidonate was
seen within 5 min in neutrophils exposed to
Arodor 1242 (Fig. 3A), and 02- production
was observed between 5 and 15 min (6).
Thus, the results are consistent with the
hypothesis that phospholipase A2 is involved
in initiation of NADPH oxidase activity in
neutrophils activated byArodor 1242.
Similar results were observed with
fMLP: release of 3H-arachidonate was seen
within 2 min (Fig. 3B) and 02- was detect-
ed within 5 min (6). The concentration-
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response relations for 3H-arachidonate
release and 02- production in neutrophils
exposed to Aroclor 1242 (Fig. 5A) are also
supportive ofthis hypothesis, as are most of
the results from studies examining the
effects of specific PCB congeners. For
example, 2,2',4,4'-TCB caused production
of02- and release of3H-arachidonate from
neutrophils at a concentration of 10 pg/ml
but not at 1 pg/ml. Conversely, 3,3',4,4'-
TCB failed to elicit either response. The
exception was 3,3',4,4',5-PeCB, which like
3,3',4,4'-TCB has high affinity for the Ah
receptor. 3,3',4,4',5-PeCB caused small,
but significant release ofarachidonic acid in
the absence of production of 02- These
results suggest that 02- generation by neu-
trophils exposed to PCBs is accompanied
by the release of arachidonic acid, but this
release is not sufficient to cause production
of02- Alternatively, 3,3',4,4',5-PeCB may
stimulate the release of arachidonic acid
from a phospholipid pool that is different
from that released in response to Aroclor
1242 and 2,2',4,4'-TCB, and this pool
may be unavailable for activation of the
NADPH oxidase.
In rat neutrophils stimulated with PMA,
it does not appear that activation ofphos-
pholipase A2 is required for initiation of02-
generation. Release of3H-arachidonate was
significant only after 20 min ofexposure to
the stimulus, while02- production occurred
much earlier (29). In addition, the magni-
tude ofrelease of3H-arachidonate was con-
siderably lower in neutrophils stimulated
with PMA when compared to the results
obtained with fMLP or Aroclor 1242,
whereas the amount of02- produced was
comparable. One explanation for these data
is that, although phospholipase A2 is
required for PMA-induced production of
02-' its role is not to initiate activation of
NADPH oxidase. An alternative explanation
for these results is that PMA activates phos-
pholipaseA2 to release low concentrations of
arachidonic acid that were not detectable by
the methods employed in thisstudy but that
are necessary and sufficient in concert with
other signal transduction pathways activated
by PMA (e.g., protein kinase C) to stimulate
production of02- This latter explanation is
consistent with previous studies using
human peripheral blood neutrophils in
which 02- production in response to PMA
was inhibited by BPB and quinacrine and
was also abolished by staurosporine, an
inhibitor of protein kinase C (14). The
effect of staurosporine was likely due to
inhibition of protein kinase C-mediated
phosphorylation and translocation of the
47-kD cytosolic factor p47, an event that
has been proposed to be required for assem-
bly and activation of the NADPH oxidase
(30,31). Thus, it appears that activation of
the NADPH oxidase by PMA in human
neutrophils requires at least two events: pro-
tein kinase C-mediated phosphorylation of
p47 and phospholipase A2-induced release
ofarachidonic acid. The same events maybe
required in rat neutrophils.
Although 02-production in response to
Aroclor 1242 was abolished completely by
10 pM manoalide (Fig. 2B), release of3H-
arachidonate was inhibited only partially
(Fig. 4). There are at least three possible
explanations for these results. One is that
arachidonate release must reach a threshold
to cause activation ofthe NADPH oxidase,
and manoalide reduces arachidonic acid to
levels below that threshold. The second is
that, although the mechanism of release of
arachidonic acid involves a phospholipase
A2 that can be inhibited by manoalide and
BPB, other phospholipases A2 may con-
tribute to overall release ofarachidonic acid.
Several isoforms ofphospholipaseA2 exist in
neutrophils, all ofwhich maynot be inhibit-
edbythecompounds used in this study. For
example, it is known that neutrophils con-
tain a cytosolic phospholipase A2 that is not
a target foreithermanoalide or BPB (20).
A third possible explanation for the
partial inhibition ofarachidonate release by
manoalide is that mechanisms independent
of phospholipase A2 are responsible, in
part, for the release of arachidonic acid in
stimulated neutrophils. One potential
mechanism involves phospholipase D-
dependent conversion of phoshatidyl-
choline or phosphatidylethanolamine to
phosphatidic acid and subsequent release of
arachidonic acid from diglyceride and
monoglyceride by the actions ofdiglyceride
lipase and monoglyceride lipase, respective-
ly (20). Another potential source ofarachi-
donic acid in activated neutrophils is dia-
cylglycerol lipase-dependent release from
diacylglycerol, which arises from mem-
brane phosphoinositides as a consequence
of phospholipase C activation (32).
Although these pathways contribute less
total arachidonic acid than phospholipase
A2 (32), they may be responsible for the
arachidonate released in Aroclor 1242-acti-
vated neutrophils that was insensitive to
manoalide. Indeed, in rat neutrophils
exposed to PCBs, phospholipase C activity
is increased (6), and diacylglycerol levels
are likely to be elevated. Further studies are
needed to address the role of these path-
ways in the release of arachidonic acid in
neutrophils exposed to PCBs.
It is likely that arachidonic acid, rather
than its metabolites, is responsible for stim-
ulation ofNADPH oxidase activity in neu-
trophils activated with Aroclor 1242.
Inhibitors of cyclooxygenase and of 5-
lipoxygenase as well as the PAF receptor
antagonist WEB 2086 failed to alter 02-
production in response to Aroclor 1242,
fMLP, or PMA. These results are consis-
tent with those obtained using other agents
that stimulate neutrophils. Exposure of
human neutrophils to exogenous arachido-
nate activates the NADPH oxidase (33,34),
and this response is unaffected by
inhibitors of the lipoxygenase or cyclooxy-
genase pathways. In addition, several other
unsaturated fatty acids that are not sub-
strates for metabolism via these pathways
(e.g., linoleic, oleic, docosahexanoic, and
eicosapentaenoic acid) also stimulate respi-
ratory burst activity in intact neutrophils
(34,35). Thus, it appears that phospholi-
pase A2-mediated release of arachidonic
acid (or other unsaturated fatty acids) is an
important event in activation of rat neu-
trophils by PCBs.
The role of arachidonic acid in activa-
tion of NADPH oxidase and consequent
production of 02- has been reported in
human peripheral blood neutrophils in
response to soluble mediators (12,14) as
well as particulate stimuli (14). To our
knowledge, this is the first report demon-
strating a role for phospholipase A2 in acti-
vation ofrat neutrophils. The results ofthe
present study suggest that, in addition to
PCBs, PMA and fMLP activate rat neu-
trophils bya mechanism similar to that seen
in human peripheral blood neutrophils and
that involves phospholipase A2-dependent
release of arachidonic acid. Furthermore,
this response is an effect ofarachidonic acid
itselfand not its metabolites.
In conclusion, the results presented in
this study are consistent with the hypothesis
that neutrophils, upon exposure to Aroclor
1242, produce 02- by a mechanism that
involves phospholipase A2-dependent release
of arachidonic acid. The release of arachi-
donic acid byinflammatory cells upon expo-
sure to PCBs may represent an additional
mechanism of PCB-induced toxicity.
Arachidonic acid and its metabolites have
been implicated in a variety ofinflammatory
disease states including septicemia (36,3N),
rheumatoid arthritis (38), andsystemiclupus
erythematosus (39), as well as diseases char-
acterized by cellular transformation such as
hypertrophic transformation ofthe skin (40)
and colon cancer (41). In addition, arachi-
donic acid has been implicated as a cytotoxi-
cant in various models of tissue injury
(42,43), and activation ofphospholipase A2
is required for the cytotoxic effects of
cytokines such as tumor necrosis factor (44).
Therefore, the activation ofphospholipase
A2 and subsequent release of arachidonic
acid from cells exposed to PCBs may be
important in mechanisms ofPCB toxicity.
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